| Literature DB >> 31768252 |
Zikria Saleem1,2, Hamid Saeed3, Mohamed Azmi Hassali1, Brian Godman1,4,5,6, Usama Asif7, Mahrukh Yousaf7, Zakiuddin Ahmed8, Humayun Riaz9, Syed Atif Raza3.
Abstract
Background: The inappropriate use of antibiotics in hospitals increases resistance, morbidity, and mortality. Little is currently known about appropriate antibiotic use among hospitals in Lahore, the capital city of Pakistan.Entities:
Keywords: Antibiotics, hospitals; Appropriateness; Pakistan; Prescribing
Mesh:
Substances:
Year: 2019 PMID: 31768252 PMCID: PMC6873729 DOI: 10.1186/s13756-019-0649-5
Source DB: PubMed Journal: Antimicrob Resist Infect Control ISSN: 2047-2994 Impact factor: 4.887
Demographic & clinical characteristics (n = 1185)
| Parameters | Frequency ( | Percentage (%) |
|---|---|---|
| Public sector | 636 | 53.7 |
| Private sector | 549 | 46.3 |
| Male | 595 | 50.2 |
| Female | 590 | 49.8 |
| Single | 514 | 43.4 |
| Combination | 671 | 56.6 |
| Gastroenterology ward | 306 | 25.8 |
| Pulmonology ward | 279 | 23.5 |
| Nephrology ward | 272 | 22.9 |
| General ward | 174 | 14.8 |
| Orthopedic ward | 154 | 12.9 |
| Appropriate | 353 | 29.7 |
| Inappropriate | 832 | 70.3 |
n = Total No. of patients involved in this study
Indication and inappropriateness of antibiotic use among patients involved in study (n = 1185)
| Indication | Patient receiving antibiotics | Inappropriate | |
|---|---|---|---|
| Frequency ( | Percent (%) | ||
| Skin and soft tissue infection | 363 | 30.7 | 285 (78.5) |
| Respiratory tract infection | 323 | 27.2 | 203 (62.8) |
| Urinary tract infection | 183 | 15.4 | 138 (75.4) |
| Gastrointestinal infection | 140 | 11.8 | 96 (68.6) |
| Pre-operative Prophylaxis | 142 | 12.0 | 96 (67.6) |
| Blood stream infection | 34 | 3.0 | 14 (41.2) |
Antibiotics prescribed to hospitalized patients (n = 2022)
| Antibiotic (ATC codes) | Frequency prescribed ( | Percentage (%) |
|---|---|---|
| 283 | 14 | |
| Narrow and broad spectrum | 120 | 42.4 |
| Ampicillin (J01CA01) | 14 | 0.7 |
| Amoxicillin (J01CA04) | 27 | 1.3 |
| Penicillin v (J01 CE08) | 79 | 3.9 |
| Combination with β-lactamase inhibitor | 163 | 57.6 |
| Amoxicillin and clavulanic acid (J01CR02) | 114 | 5.6 |
| Piperacillin + tazobactam (J01CR05) | 49 | 2.4 |
| 933 | 46.1 | |
| 1st generation | 114 | 12.2 |
| Cephalexin (J01DB01) | 31 | 0.2 |
| Cefazolin (J01DB04) | 86 | 4.3 |
| Cephradine (J01DB09) | 25 | 1.3 |
| 2nd generation | 83 | 8.9 |
| Cefuroxime (J01 DC02) | 72 | 3.6 |
| Cefaclor (J01 DC04) | 11 | 0.5 |
| 3rd generation | 729 | 78.1 |
| Cefotaxime (J01DD01) | 23 | 1.4 |
| Ceftazidime (J01DD02) | 20 | 0.9 |
| Ceftriaxone (J01DD04) | 423 | 21 |
| Cefixime (J01DD08) | 32 | 1.6 |
| Cefoperazone and salbactum (J01DD62) | 231 | 11.4 |
| 4th generation | 7 | 0.80 |
| Cefepime (J01DE01) | 7 | 0.3 |
| 31 | 1.5 | |
| Imipenem (J01DH51) | 9 | 0.4 |
| Meropenem (J01DH02) | 22 | 1 |
| 59 | 2.9 | |
| Erythromycin (J01FA01) | 4 | 0.2 |
| Clarithromycin (J01FA09) | 48 | 2.4 |
| Azithromycin (J01FA10) | 7 | 0.3 |
| 315 | 15.6 | |
| Gentamicin (J01GB03) | 8 | 0.4 |
| Amikacin (J01GB06) | 307 | 15.2 |
| 193 | 9.5 | |
| Ciprofloxacin (J01MA02) | 130 | 6.4 |
| Levofloxacin (J01MA12) | 17 | 0.8 |
| Moxifloxacin (J01MA14) | 41 | 2 |
| Ofloxacin (J01MA01) | 3 | 0.1 |
| Norfloxacin (J01MA06) | 2 | 0.09 |
| 208 | 10.4 | |
| Vancomycin (J01XA01) | 80 | 4.0 |
| Metronidazole (J01XD01) | 119 | 5.9 |
| Linezolid (J01XX08) | 9 | 0.5 |
Inappropriate antibiotic Usage (n = 2022)
| Antibiotics | Inappropriate indication | Inappropriate dosage | Inappropriate treatment |
|---|---|---|---|
| Penicillins | 173 (61.1) | 140 (49.5) | 201 (71.0) |
| Narrow/broad spectrum | 81 (67.5) | 92 (76.7) | 102 (85.0) |
| With β-lactamase inhibitor | 92 (56.4) | 48 (29.5) | 99 (60.7) |
| Cephalosporins | 470 (50.4) | 418 (44.8) | 627 (67.2) |
| 1st generation | 37 (32.5) | 72 (86.7) | 92 (80.7) |
| 2nd generation | 32 (38.5) | 49 (59.1) | 66 (79.5) |
| 3rd generation | 395 (54.2) | 293 (40.2) | 463 (63.5) |
| 4th generation | 6 (85.7) | 4 (57.1) | 6 (85.7) |
| Carbapenems | 20 (76.6) | 18 (58.1) | 22 (70.9) |
| Macrolides | 37 (62.7) | 29 (49.2) | 44 (74.6) |
| Aminoglycosides | 67 (21.2) | 84 (26.6) | 113 (35.8) |
| Fluoroquinolones | 71 (36.8) | 108 (55.9) | 124 (64.2) |
| Others Antibacterial | 67 (32.2) | 133 (63.9) | 152 (73.1) |